Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin

@article{Burmeister2005FeasibilityOC,
  title={Feasibility of chemoradiation therapy with protracted infusion of5-fluorouracil for esophageal cancer patients not suitable for cisplatin},
  author={Bryan H. Burmeister and Euan Thomas Walpole and Elizabeth A Burmeister and J. Meyrick Thomas and Damien B. Thomson and Jennifer A. Harvey and Bernard Mark Smithers and David C. Gotley},
  journal={International Journal of Clinical Oncology},
  year={2005},
  volume={10},
  pages={256-261}
}
Chemoradiation therapy is the standard treatment for esophageal cancer in patients not fit for surgery. The regimen most commonly used includes cisplatin and 5-fluorouracil. Little data exists regarding alternative chemotherapy regimens in patients not suitable for cisplatin. We report on a regimen using protracted infusion 5-fluorouracil alone for both curative and palliative indications. Twenty-two patients with localized esophageal cancer suitable for curative chemoradiation therapy and24… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-7 of 7 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 26 references

Similar Papers

Loading similar papers…